CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $5.68 million. The enterprise value is -$7.16 million.
Important Dates
The next estimated earnings date is Tuesday, June 17, 2025, after market close.
Earnings Date | Jun 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CNSP has 5.46 million shares outstanding.
Current Share Class | 5.46M |
Shares Outstanding | 5.46M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +153.86% |
Owned by Insiders (%) | 0.19% |
Owned by Institutions (%) | 1.26% |
Float | 5.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.28 |
P/TBV Ratio | 0.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.94 |
Quick Ratio | 4.69 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -999.47 |
Financial Efficiency
Return on equity (ROE) is -477.53% and return on invested capital (ROIC) is -281.74%.
Return on Equity (ROE) | -477.53% |
Return on Assets (ROA) | -127.31% |
Return on Invested Capital (ROIC) | -281.74% |
Return on Capital Employed (ROCE) | -143.07% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.12M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.61% in the last 52 weeks. The beta is 0.78, so CNSP's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | -99.61% |
50-Day Moving Average | 1.12 |
200-Day Moving Average | 4.49 |
Relative Strength Index (RSI) | 42.17 |
Average Volume (20 Days) | 4,910,380 |
Short Selling Information
The latest short interest is 731,730, so 13.40% of the outstanding shares have been sold short.
Short Interest | 731,730 |
Short Previous Month | 629,853 |
Short % of Shares Out | 13.40% |
Short % of Float | 13.45% |
Short Ratio (days to cover) | 0.17 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.69M |
Pretax Income | -17.46M |
Net Income | -15.61M |
EBITDA | -15.69M |
EBIT | -15.69M |
Earnings Per Share (EPS) | -$14.69 |
Full Income Statement Balance Sheet
The company has $13.05 million in cash and $210,673 in debt, giving a net cash position of $12.84 million or $2.35 per share.
Cash & Cash Equivalents | 13.05M |
Total Debt | 210,673 |
Net Cash | 12.84M |
Net Cash Per Share | $2.35 |
Equity (Book Value) | 10.97M |
Book Value Per Share | 3.73 |
Working Capital | 10.94M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$17.16 million and capital expenditures -$4,188, giving a free cash flow of -$17.17 million.
Operating Cash Flow | -17.16M |
Capital Expenditures | -4,188 |
Free Cash Flow | -17.17M |
FCF Per Share | -$3.14 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |